Tradestie Institutional Equity Comparison Engine

GBFH vs BCAL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BCAL Overall Edge

BCAL Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to California BanCorp Common Stock (BCAL) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, GBFH trades at 23.4x Forward P/E with 38.5% operating margin (-1.5% YoY revenue) versus BCAL at 11.2x Forward P/E and 48.1% operating margin (-5.2% YoY). In options structure, GBFH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BCAL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BCAL
GBFH 23.4x vs BCAL 11.2x Fwd P/E
Growth & Margin Winner BCAL
Op Margin 38.5% vs 48.1% ยท YoY -1.5% vs -5.2%
Momentum & Technical Winner BCAL
1Y -57.5% vs +15.7% ยท 52W Pos 11% vs 75%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GBFH NASDAQ
GBank Financial Holdings Inc. Common Stock
State Commercial Banks
$14.39
-3.36% 1D
Market Cap $217.0M
1M Return -15.25%
1Y Return -57.54%
Forward P/E 23.4x
Unified AI Score
40.0 / 100 SELL
Tech 25.0 Fund 61.0 Flow 50.0 Mom 69.0
BCAL NASDAQ
California BanCorp Common Stock
National Commercial Banks
$21.14
-1.17% 1D
Market Cap $673.9M
1M Return -2.31%
1Y Return +15.65%
Forward P/E 11.2x
Unified AI Score
48.0 / 100 HOLD
Tech 50.0 Fund 43.0 Flow 50.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GBFH -57.54% BCAL +15.65% Spread: +73.19 pp (BCAL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GBFH TTM Op. Margin: 38.5% BCAL TTM Op. Margin: 48.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GBFH vs BCAL. Trailing 12-month operating profitability (GBFH 38.5% vs BCAL 48.1%) and valuation multiples (GBFH 23.4x vs BCAL 11.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GBFH (2) vs BCAL (8)
Institutional Metric GBFH BCAL Criterion Row Winner
Market Capitalization Scale $217.0M $673.9M Larger Scale BCAL
Trailing P/E Ratio Valuation 12.0x 11.7x Lower Multiple BCAL
Forward P/E Ratio Valuation 23.4x 11.2x Lower Multiple BCAL
Revenue Growth (YoY) Growth -1.5% -5.2% Higher Growth GBFH
Operating Margin (TTM) Profitability 38.5% 48.1% Higher Margin BCAL
Net Profit Margin Profitability 24.0% 32.2% Higher Margin BCAL
Return on Equity (ROE) Capital Efficiency 10.8% 10.2% Higher ROE GBFH
52-Week Range Position Momentum 11% ($12โ€“$38) 75% ($17โ€“$23) Stronger Trend BCAL
Beta / 30D Volatility Risk Regime 0.13ฮฒ ยท 46% Vol 0.29ฮฒ ยท 18% Vol Lower Realized Risk BCAL
Unified Institutional Score Composite Signal 40.0 / 100 (SELL) 48.0 / 100 (HOLD) Higher Composite BCAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GBFH vs BCAL Buy Guide
GBFH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GBFH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BCAL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BCAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GBFH nor BCAL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.